Home
 > Business > Business Daily
Medical Treatment Industry Presents a Good Trend
Text Size:A A A 2019-10-29

13 pharmaceutical and chemical listed companies in Taizhou gradually released the performance report of the first three quarters of 2019 in recent days.


With continuously enhancing the reform of the medical system, various medical policy are issued in 2019, including the new version of the medical insurance catalogue, the generic drug catalogue, the medical insurance payment price, the catalogue of rational drug use with the state key monitoring, the cancellation of the drug proportion, the evaluation of consistency of generic drugs, orphan drugs, the shortage of drugs, and the examination and approval of new drugs. All the detailed rules for the implementation of centralized procurement of drugs in "4 + 7" cities, such as Beijing, Shanghai, Guangzhou and Shenzhen, have been released. Taizhou pharmaceutical and chemical listed enterprises are affected by the above factors. The total market value is nearly RMB20 billion, representing a significant increase compared with the beginning of the year.


In addition, Taizhou pharmaceutical and chemical industry presents a good overall situation this year, according to the recent 3rd-quarter results of Zhejiang Yongtai Technology Co., Ltd. and Zhejiang Xinnong Chemical Co., Ltd., and the forecast of the first three quarters of Zhejiang Huahai Pharmaceutical Co., Ltd. and Zhejiang Hisoar Pharmaceutical Co., Ltd.




【Print】 【Close】
Produced By 大汉网络 大汉版通发布系统